Albendazole and Anthelminthics:

1.  Horton RJ. (1989).  Chemotherapy of Echinococcus infection in man with albendazole. Trans. Roy. Soc. Med. Hyg. 84, 97‑102.

2.  Bundy DAP, Wong MS, Lewis LL, Horton RJ. (1990).  Control of A. lumbricoides and T. trichiura by age targetted chemotherapy.  Trans Roy Soc Trop Med Hyg. 84, 115‑120.

3.  Horton RJ. (1990).  The treatment of neurocysticercosis with albendazole (letter).  Trans Roy. Soc Trop Med Hyg. 84, 174.

4.  Horton RJ. (1990).  Benzimidazoles in a wormy world.  Parasitology Today. 6, 106.

5.  Cruz M, Cruz I, Horton RJ. (1991).  The treatment of neurocysticercosis with albendazole.  Trans Roy Soc Trop Med Hyg. 85, 244‑247.

6.  Horton RJ, Cruz M, Cruz I. (1991).  The efficacy of albendazole and praziquantel the treatment of neurocysticercosis.  S E Asian J Trop Med Public Health. 22, 279-283.

7.  Horton RJ. (1991).  Reinfection of Somali Children with Trichuris trichuria (letter) Trans Roy Soc Trop Med Hyg. 85, 697.

8.  Cruz ME, Cruz I, Horton RJ. (1991)  Albendazol vs. Praziquantel en el Tratamiento de la Neurocisticercosis:  Evaluacion Clinica.  En: Teniasis/Cisticercosis en el Ecuador, M E Cruz, ed. Ministerio de Salud Publica, Quito, pp 57‑65.

9.  Cruz ME, Cruz I Horton RJ. (1991).  Comparacion de tres regimenes de albendazol para el tratamiento de la neurocisticercosis.  En: Teniasis/Cisticercosis en el Ecuador, M E Cruz ed.  Ministerio de Salud Publica, Quito, pp 66‑70.

10.  Klion AD, Massougbodji A, Horton RJ, Ekone S, Lanmasso T, Ahouisson LN, and Nutman TB. (1992).  Albendazole in human loiasis: Results of a double blind placebo controlled trial.  J. Inf. Dis. 168, 202‑206.

11.  Reynoldson JA, Thompson RCA, Horton J (1992).  Albendazole as a future antigiardial agent.  Parasitology Today.  8, 412-414.

12.  Horton J (1993).  The use of antiprotozoan and anthelminthic drugs during pregnancy.  J Infection, 26, 104-105.

13.  Cruz I, Cruz ME, Carrasco F, Horton J (1995).  Neurocysticercosis: optimal dose treatment with albendazole.  J Neurol Sci. 133, 152-154.

14.  Horton J (1996).  Albendazole: A review of the pharmacology, pharmacokinetics, clinical efficacy and safety in hydatid disease.  In: Alveolar Echinococcosis: Strategy for the Eradication of Alveolar Echinococcosis of the Liver.  (Eds: Uchino J & Sato N)  pp 261-279.

15.  Horton J (1996).  Biology of tapeworm disease.  Lancet. 348 481. (Letter)

16.  WHO Informal Working Group on Echinococcosis (1996) Guidelines for treatment of cystic and alveolar echinococcosis in humans.  Bull WHO. 74, 231-242

17.  Horton RJ. (1997).  Albendazole in the treatment of human cystic echinococcosis: 12 years of experience.  Acta Tropica.  64, 79 - 93

18.  Garcia HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, Cuba JM, Rios-Saavedra N, Verastegui M, Boero J, Gonzalez AE (1997). Albendazole therapy for neurocysticercosis: a prospective double blind trial comparing 7 versus 14 days of treatment.  Neurology.  48, 1421 - 1427.

19.  Molina J-M, Chastang C, Goguel J, Michiels J-M, Safarti C, Desportes-Livage I, Horton, J, Derouin F, Modai J (1998).  A randomised double-blind controlled trial of albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS.  Journal of Infectious Diseases. 177, 1373-1377.

20.  Reynoldson JA, Behnke JM, Gracey M, Horton RJ, Spargo R, Hopkins R, Constantine CC, Gilbert F, Stead C, Hobbs RP, Thompson RCA, (1998) Efficacy of albendazole against Giardia and hookworm in a remote aboriginal community in North Western Australia.  Acta Tropica. 71, 27-44

21.  Horton J. (1998). Evaluation of microfilaricidal and macrofilaricidal compounds. Trans.Roy Soc Trop Med Hyg.92, 688

22.  Savioli L (and others incl. Horton J) (1999).  Treatment of trichuris infection with albendazole (letter)  Lancet. 353, 237

23.  Olds GR, King, C, Hewlett J .... Horton J, Reeve P. (1999).  Double blind placebo controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths.  J Infect Dis.  179, 996-1003

24.  Ottesen EA, Ismail MM, Horton J (1999). The role of albendazole in programmes to eliminate lymphatic filariasis.  Parasitology Today. 15, 382-386

25.  Klion AD, Horton J, Nutman TB (1999).  Albendazole therapy for loaisis refactory to diethylcarbamazine treatment.  Clin Infect Dis. 29, 680 –682

26.  Horton J, Ahonkhai VI (2000).  New anthelminthic drugs in pediatrics.  Seminars in Pediatric Infectious Disease.  Seminars in Pediatric Infectious Diseases 11, 275-279

27.  Gallia E, Horton J, Dressman JB. (1999)  Albendazole Generics – a comparative in vitro study.  Pharmaceutical Research. 16, 1871-1875

28.  Horton J (2000). The efficacy of anthelminthics: past present and future. (Supplement – Proceedings of Bali Conference on the Control of Soil Transmitted Nematodes)   World Health Organisation [In Press]

29.  Bradley M, Horton J (2001).  Assessing the risk: benzimidazole therapy in pregnancy.  Trans Roy Soc Trop Med Hyg.  95, 72-73

30.  Horton J (2000).  Albendazole: a review of efficacy and safety in humans.  In: Lymphatic Filariasis Control (eds: Stephenson L & Ottessen E).  Parasitology. 121 S113-S132

31.  Horton J et al (2000) An Analysis of the Safety of Drug Combinations for the Control and Treatment of Lymphatic Filariasis In: Lymphatic Filariasis Control (eds: Stephenson L & Ottessen E)  Parasitology. 121 S147-S160

  1. Horton J (2002).  Albendazole Recent Advances for an old anthelmithic.  Current Opinion in Infectious Diseases.  In Press
  2. Horton J (2002).  Albendazole in Echinococcal Disease – the importance of Clinical Pharmacology.  European Journal Clinical Pharmacology.  In Press